Date: August 1, 2023
Time: 10:00 AM (PDT), 1:00 PM (EDT), 7:00 PM (CEST)
Human cytomegalovirus (CMV) infection is common and usually results in a mild, non-specific illness in otherwise healthy individuals, followed by asymptomatic latency. However, congenital CMV (cCMV) infection during fetal development can cause severe symptoms in newborns, including developmental delays, hearing loss, and even death. It is underappreciated that CMV causes more cases of congenital disease than the 29 most commonly screened metabolic and endocrine disorders combined, and that congenital CMV is the leading cause of non-genetic sensorineural hearing loss and neurodevelopmental abnormalities in infants. Early detection of cCMV infection is critical for timely clinical intervention, including treatment with antiviral medications, which may lessen the severity of the hearing and developmental impairments associated with this infection. This seminar will review the standard of care for cCMV diagnosis, evaluation, and treatment, and explore areas of opportunity. The impacts of advocacy and education for cCMV will also be discussed.
Learning Objectives
- Understand the standard of care for cCMV diagnosis, evaluation, and treatment
- Recognize areas in care for which evidence is lacking, unclear, or pending
- Gain awareness of the family experience and the impact of their cCMV advocacy work
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.